What is Tango Therapeutics's short- term investments?

Tango Therapeutics (TNGX) reported short- term investments of $222.01M in Q1 2026.

How has Tango Therapeutics's short- term investments changed year-over-year?

Tango Therapeutics's short- term investments increased by 40.3% year-over-year, from $158.29M to $222.01M.

What is the long-term trend for Tango Therapeutics's short- term investments?

Over 5 years (2020 to 2025), Tango Therapeutics's short- term investments has grown at a 7.3% compound annual growth rate (CAGR), from $161.94M to $230.86M.

Tango Therapeutics TNGX Short- term Investments

Short- term Investments at other companies

Gilead SciencesGILD

——

ExelixisEXEL

——

CG OncologyCGON

——

ImmunityBio, Inc.IBRX

——

Roivant SciencesROIV

——

Nuvalent, Inc.NUVL

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's short- term investments?: Tango Therapeutics (TNGX) reported short- term investments of $222.01M in Q1 2026.
How has Tango Therapeutics's short- term investments changed year-over-year?: Tango Therapeutics's short- term investments increased by 40.3% year-over-year, from $158.29M to $222.01M.
What is the long-term trend for Tango Therapeutics's short- term investments?: Over 5 years (2020 to 2025), Tango Therapeutics's short- term investments has grown at a 7.3% compound annual growth rate (CAGR), from $161.94M to $230.86M.